Fungal Meningitis Case Outbreak - What You Should Know
Wednesday, October 10, 2012

Health Alert

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have determined that the source of the recent multistate outbreak of fungal meningitis is linked to injectable medication manufactured by the New England Compounding Center (NECC) in Framingham, Mass. The CDC and FDA have confirmed the presence of fungus in unopened medication vials of preservative-free methylprednisolone acetate. The company has recalled all of its products, however, it is estimated that 13,000 people may have been exposed since May 2012.

Kennedy Health System has not used any of the NECC medications suspected in the outbreak.  If you have questions related to a recent procedure, please contact your health care provider.

You may also access additional information via the following links:

•                    Latest news on the meningitis outbreak from the FDA -  http://www.fda.gov/Drugs/DrugSafety/ucm322734.htm

•                    Meningitis information and guidance from the CDC - http://www.cdc.gov/HAI/outbreaks/meningitis.html